{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:48:48Z","timestamp":1773298128671,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1378\/chest.124.5.2028","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T22:17:59Z","timestamp":1068157079000},"page":"2028-2031","source":"Crossref","is-referenced-by-count":91,"title":["Refractory Sarcoidosis Responding to Infliximab *"],"prefix":"10.1016","volume":"124","author":[{"given":"Scott D.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Wilkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Burgett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth S.","family":"Knox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.124.5.2028_bib1","first-page":"70","article-title":"Infliximab for refractory sarcoidosis","volume":"18","author":"Baughman","year":"2001","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1378\/chest.124.5.2028_bib2","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/01.WNL.0000034766.13282.33","article-title":"Refractory neurosarcoidosis responding to infliximab","volume":"59","author":"Pettersen","year":"2002","journal-title":"Neurology"},{"key":"10.1378\/chest.124.5.2028_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-135-1-200107030-00010","article-title":"Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy","volume":"135","author":"Yee","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.124.5.2028_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1067\/mjd.2003.228","article-title":"Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy","volume":"48","author":"Mallbris","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1378\/chest.124.5.2028_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1378\/chest.103.1.253","article-title":"Myocardial sarcoidosis","volume":"103","author":"Sharma","year":"1993","journal-title":"Chest"},{"key":"10.1378\/chest.124.5.2028_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1183\/09031936.96.09010047","article-title":"Pulmonary sarcoidosis: patterns of cytokine releasein vitro","volume":"9","author":"Prior","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.124.5.2028_bib7","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","article-title":"TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection","volume":"168","author":"Roach","year":"2002","journal-title":"J Immunol"},{"key":"10.1378\/chest.124.5.2028_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1378\/chest.119.3.753","article-title":"The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis","volume":"119","author":"Yamaguchi","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.124.5.2028_bib9","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1164\/ajrccm.155.5.9154873","article-title":"Pentoxifylline in treatment of sarcoidosis","volume":"155","author":"Zabel","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.5.2028_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1378\/chest.122.1.227","article-title":"Thalidomide for chronic sarcoidosis","volume":"122","author":"Baughman","year":"2002","journal-title":"Chest"},{"key":"10.1378\/chest.124.5.2028_bib11","first-page":"167","article-title":"Update of ocular manifestations in sarcoidosis","volume":"19","author":"Usui","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"suppl","key":"10.1378\/chest.124.5.2028_bib12","first-page":"A495","article-title":"Double blind randomized trial of a tumor necrosis factor antagonist (etanercept) for treatment of chronic ocular sarcoidosis [abstract]","volume":"165","author":"Baughman","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.5.2028_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1520\/JFS16209J","article-title":"Cardiac sarcoidosis: an occult cause of sudden death; a case report and literature review","volume":"43","author":"Veinot","year":"1998","journal-title":"J Forensic Sci"},{"key":"10.1378\/chest.124.5.2028_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11936-000-0034-x","article-title":"Sarcoidosis and the heart","volume":"2","author":"Shabetai","year":"2000","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1378\/chest.124.5.2028_bib15","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","article-title":"Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration","volume":"46","author":"Brown","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.124.5.2028_bib16","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00042737-200212000-00018","article-title":"Disseminated cytomegalovirus infection in Crohn\u2019s disease following anti-tumour necrosis factor therapy","volume":"14","author":"Helbling","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1378\/chest.124.5.2028_bib17","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.124.5.2028_bib18","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/rccm.200206-563OC","article-title":"Histoplasmosis after treatment with anti-TNF-\u03b1 therapy","volume":"167","author":"Wood","year":"2003","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215334486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215334486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T09:53:03Z","timestamp":1550397183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215334486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0012369215334486"],"URL":"https:\/\/doi.org\/10.1378\/chest.124.5.2028","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}